Differential Diagnosis of Jakob-Creutzfeldt Disease

被引:66
|
作者
Paterson, Ross W. [1 ]
Torres-Chae, Charles C. [1 ]
Kuo, Amy L. [1 ]
Ando, Tim [1 ]
Nguyen, Elizabeth A. [1 ]
Wong, Katherine [1 ]
DeArmond, Stephen J. [2 ]
Haman, Aissa [1 ]
Garcia, Paul [1 ]
Johnson, David Y. [1 ]
Miller, Bruce L. [1 ]
Geschwind, Michael D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
RAPIDLY PROGRESSIVE DEMENTIA; PRION DISEASE; VARIANT CJD; PATTERNS; FLUID;
D O I
10.1001/2013.jamaneurol.79
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To identify the misdiagnoses of patients with sporadic Jakob-Creutzfeldt disease (sCJD) during the course of their disease and determine which medical specialties saw patients with sCJD prior to the correct diagnosis being made and at what point in the disease course a correct diagnosis was made. Design: Retrospective medical record review. Setting: A specialty referral center of a tertiary academic medical center. Participants: One hundred sixty-three serial patients over a 5.5-year period who ultimately had pathologically proven sCJD. The study used the subset of 97 patients for whom we had adequate medical records. Main Outcome Measures: Other diagnoses considered in the differential diagnosis and types of medical specialties assessing patients with sCJD. Results: Ninety-seven subjects' records were used in the final analysis. The most common disease categories of misdiagnosis were neurodegenerative, autoimmune/paraneoplastic, infectious, and toxic/metabolic disorders. The most common individual misdiagnoses were viral encephalitis, paraneoplastic disorder, depression, vertigo, Alzheimer disease, stroke, unspecified dementia, central nervous system vasculitis, peripheral neuropathy, and Hashimoto encephalopathy. The physicians who most commonly made these misdiagnoses were primary care physicians and neurologists; in the 18% of patients who were diagnosed correctly at their first assessment, the diagnosis was almost always by a neurologist. The mean time from onset to diagnosis was 7.9 months, an average of two-thirds of the way through their disease course. Conclusions: Diagnosis of sCJD is quite delayed. When evaluating patients with rapidly progressive dementia with suspected neurodegenerative, autoimmune, infectious, or toxic/metabolic etiology, sCJD should also be included in the differential diagnosis, and appropriate diagnostic tests, such as diffusion brain magnetic resonance imaging, should be considered. Primary care physicians and neurologists need improved training in sCJD diagnosis. Arch Neurol. 2012; 69(12): 1578-1582. Published online September 24, 2012. doi:10.1001/2013.jamaneurol.79
引用
收藏
页码:1578 / 1582
页数:5
相关论文
共 50 条
  • [21] Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease
    Wang, Leo H.
    Bucelli, Robert C.
    Patrick, Erica
    Rajderkar, Dhanashree
    Alvarez, Enrique, III
    Lim, Miranda M.
    DeBruin, Gabriela
    Sharma, Victoria
    Dahiya, Sonika
    Schmidt, Robert E.
    Benzinger, Tammie S.
    Ward, Beth A.
    Ances, Beau M.
    JOURNAL OF NEUROLOGY, 2013, 260 (02) : 498 - 506
  • [22] Rapid cognitive and functional decline: Creutzfeldt-Jakob disease
    Dameron, Matthew
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (09):
  • [23] Creutzfeldt-Jakob disease - diagnostic methods
    Makowska, Marianna
    AKTUALNOSCI NEUROLOGICZNE, 2013, 13 (03): : 195 - 200
  • [24] Subtype Diagnosis of Sporadic Creutzfeldt-Jakob Disease with Diffusion Magnetic Resonance Imaging
    Bizzi, Alberto
    Pascuzzo, Riccardo
    Blevins, Janis
    Moscatelli, Marco E. M.
    Grisoli, Marina
    Lodi, Raffaele
    Doniselli, Fabio M.
    Castelli, Gianmarco
    Cohen, Mark L.
    Stamm, Aymeric
    Schonberger, Lawrence B.
    Appleby, Brian S.
    Gambetti, Pierluigi
    ANNALS OF NEUROLOGY, 2021, 89 (03) : 560 - 572
  • [25] Reactive microglia in Creutzfeldt-Jakob disease
    Muhleisen, H
    Gehrmann, J
    Meyermann, R
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (06) : 505 - 517
  • [26] Variant Creutzfeldt-Jakob disease: an update
    Ironside, James W.
    FOLIA NEUROPATHOLOGICA, 2012, 50 (01) : 50 - 56
  • [27] The new variant of Creutzfeldt-Jakob disease
    Zeidler, M
    Ironside, JW
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2000, 19 (01): : 98 - 120
  • [28] Variant Creutzfeldt-Jakob disease: an update
    Ironside, James W.
    AKTUALNOSCI NEUROLOGICZNE, 2011, 11 (01): : 44 - 48
  • [29] Neuropathology of variant Creutzfeldt-Jakob disease
    Ironside, JW
    Head, MW
    McCardle, L
    Knight, R
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2002, 62 (03) : 175 - 182
  • [30] Pathology of variant Creutzfeldt-Jakob disease
    Ironside, JW
    PRIONS: FOOD AND DRUG SAFETY, 2005, : 1 - 14